News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
335,930 Results
Type
Article (12030)
Company Profile (62)
Press Release (323830)
Multimedia
Podcasts (14)
Webinars (9)
Section
Business (108424)
Career Advice (671)
Deals (17856)
Drug Delivery (28)
Drug Development (35309)
Employer Resources (57)
FDA (5638)
Job Trends (6571)
News (167269)
Policy (11561)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1123)
Accelerated approval (10)
Adcomms (7)
Allergies (53)
Alliances (23360)
ALS (87)
Alzheimer's disease (808)
Antibody-drug conjugate (ADC) (114)
Approvals (5805)
Artificial intelligence (229)
Autoimmune disease (63)
Automation (17)
Bankruptcy (121)
Best Places to Work (5271)
BIOSECURE Act (1)
Biosimilars (65)
Biotechnology (45)
Bladder cancer (73)
Brain cancer (22)
Breast cancer (277)
Cancer (2091)
Cardiovascular disease (208)
Career advice (588)
Career pathing (14)
CAR-T (122)
CDC (11)
Cell therapy (325)
Cervical cancer (10)
Clinical research (30041)
Collaboration (814)
Compensation (417)
Complete response letters (13)
COVID-19 (992)
CRISPR (51)
C-suite (545)
Cystic fibrosis (71)
Data (3091)
Denatured (6)
Depression (58)
Diabetes (206)
Diagnostics (3258)
Digital health (11)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (116)
Drug pricing (29)
Drug shortages (4)
Duchenne muscular dystrophy (98)
Earnings (47457)
Editorial (17)
Employer branding (10)
Employer resources (56)
Events (56330)
Executive appointments (628)
FDA (6966)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (739)
Gene editing (87)
Generative AI (19)
Gene therapy (252)
GLP-1 (350)
Government (1282)
Grass and pollen (1)
Guidances (234)
Healthcare (7903)
HIV (35)
Huntington's disease (13)
IgA nephropathy (32)
Immunology and inflammation (79)
Immuno-oncology (20)
Indications (42)
Infectious disease (1081)
Inflammatory bowel disease (92)
Inflation Reduction Act (3)
Influenza (34)
Intellectual property (78)
Interviews (84)
IPO (8835)
IRA (10)
Job creations (1527)
Job search strategy (530)
JPM (18)
Kidney cancer (12)
Labor market (21)
Layoffs (178)
Leadership (10)
Legal (2928)
Liver cancer (39)
Longevity (7)
Lung cancer (254)
Lymphoma (150)
Machine learning (23)
Management (19)
Manufacturing (297)
MASH (80)
Medical device (5266)
Medtech (5284)
Mergers & acquisitions (9572)
Metabolic disorders (510)
Multiple sclerosis (61)
NASH (6)
Neurodegenerative disease (146)
Neuropsychiatric disorders (37)
Neuroscience (1386)
Neurotech (1)
NextGen: Class of 2026 (2650)
Non-profit (1944)
Now hiring (15)
Obesity (217)
Opinion (100)
Ovarian cancer (63)
Pain (72)
Pancreatic cancer (82)
Parkinson's disease (140)
Partnered (15)
Patents (129)
Patient recruitment (199)
Peanut (18)
People (36974)
Pharmaceutical (15)
Pharmacy benefit managers (3)
Phase 1 (8984)
Phase 2 (12865)
Phase 3 (10510)
Pipeline (2872)
Policy (74)
Postmarket research (1088)
Preclinical (4651)
Press Release (69)
Prostate cancer (115)
Psychedelics (19)
Radiopharmaceuticals (155)
Rare diseases (372)
Real estate (2748)
Recruiting (21)
Regulatory (9013)
Reports (19)
Research institute (1216)
Resumes & cover letters (91)
Rett syndrome (23)
RNA editing (5)
RSV (15)
Schizophrenia (77)
Series A (140)
Series B (79)
Sickle cell disease (44)
Special edition (2)
Spinal muscular atrophy (90)
Sponsored (20)
Startups (1847)
State (1)
Stomach cancer (4)
Supply chain (29)
Tariffs (13)
The Weekly (8)
Vaccines (295)
Venture capital (29)
Weight loss (98)
Women's health (33)
Worklife (2)
Date
Today (7)
Last 7 days (276)
Last 30 days (1114)
Last 365 days (14929)
2026 (1394)
2025 (14967)
2024 (17277)
2023 (20110)
2022 (26818)
2021 (28920)
2020 (26644)
2019 (20541)
2018 (15820)
2017 (15760)
2016 (14731)
2015 (17940)
2014 (13793)
2013 (10950)
2012 (11605)
2011 (12285)
2010 (11593)
Location
Africa (316)
Alabama (32)
Alaska (5)
Arizona (115)
Arkansas (3)
Asia (17579)
Australia (2782)
California (5409)
Canada (1755)
China (396)
Colorado (242)
Connecticut (249)
Delaware (142)
Europe (42087)
Florida (770)
Georgia (142)
Hawaii (1)
Idaho (30)
Illinois (314)
India (23)
Indiana (195)
Iowa (13)
Japan (243)
Kansas (49)
Kentucky (21)
Louisiana (15)
Maine (54)
Maryland (591)
Massachusetts (4406)
Michigan (201)
Minnesota (256)
Mississippi (3)
Missouri (67)
Montana (19)
Nebraska (17)
Nevada (63)
New Hampshire (27)
New Jersey (1526)
New Mexico (22)
New York (1463)
North Carolina (734)
North Dakota (5)
Northern California (2699)
Ohio (197)
Oklahoma (10)
Oregon (25)
Pennsylvania (1043)
Puerto Rico (5)
Rhode Island (31)
South America (431)
South Carolina (21)
Southern California (2106)
Tennessee (87)
Texas (838)
United States (19631)
Utah (199)
Vermont (1)
Virginia (125)
Washington D.C. (28)
Washington State (464)
West Virginia (3)
Wisconsin (85)
Wyoming (1)
335,930 Results for "proveris scientific corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation
January 12, 2026
·
7 min read
Press Releases
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
January 8, 2026
·
4 min read
Press Releases
Eurobio Scientific: 2025 FY revenue
January 28, 2026
·
4 min read
Press Releases
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board
A renowned expert in insulin pharmacology, diabetes technology, and temperature-sensitive medication stability joins TempraMed to strengthen scientific leadership
December 10, 2025
·
6 min read
Press Releases
Boston Scientific announces agreement to acquire Penumbra, Inc.
January 16, 2026
·
15 min read
Press Releases
Scribe Therapeutics to Demonstrate Scientific and Corporate Leadership at Upcoming Conferences
August 26, 2025
·
2 min read
Press Releases
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
October 2, 2025
·
6 min read
Press Releases
TetraScience Announces Collaboration with Thermo Fisher Scientific to Accelerate Scientific Data and AI Enablement Across the Laboratory
January 13, 2026
·
3 min read
Press Releases
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
September 10, 2025
·
6 min read
Press Releases
Boston Scientific announces results for fourth quarter and full year 2025
February 4, 2026
·
27 min read
1 of 33,593
Next
